2 FTSE 100 dividend stocks! Which should I buy for a second income?

These UK blue-chip shares are both popular dividend stocks with investors seeking a market-beating second income. Which should I buy today?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Front view photo of a woman using digital tablet in London

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Right now, I’m searching the FTSE 100 for the best dividend stocks to buy. I’m not just looking for shares that will provide healthy shareholder payouts in the short term. I’m seeking companies that can provide a sustainable and growing dividend for years to come.

The following FTSE shares offer forward dividend yields above the 3.8% index average. But which should I buy today?


Dividend yield: 4.3%. Oil giant BP (LSE:BP.) is tipped to provide a growing dividend over the next few years. It reflects economist expectations that oil prices will rise as supply issues linger.

The Brent benchmark has risen to one-year highs above $92 per barrel in recent sessions. Even though the global economy is spluttering, energy values are holding up from key producers like Saudi Arabia and Russia scaling back production.

But I’m not readying to buy BP shares for my portfolio. As someone who invests for the long term, I’m concerned by the company’s profits and dividend prospects as green energy steadily takes over.

To underline the point, International Energy Agency executive director Fatih Birol has said we are witnessing “the beginning of the end” for fossil fuels. The agency has predicted for the first time that oil, gas and coal demand will all peak before 2030 as cleaner sources rise in popularity.

BP has exposure to renewable energy sources like wind and alternative fuels including hydrogen. But this isn’t enough for my liking. And what’s more, the company has reduced planned investment in green power to 2030 and increased its oil and gas production targets.


Dividend yield: 4%. Pharmaceuticals giant GSK (LSE:GSK), on the other hand, can expect demand for its products to rise in the coming decades. Steady population growth and rising emerging market wealth could send medicines demand through the roof.

Holding shares in drugs developers can at times be a troubling experience. Failures at the lab bench and unfavourable regulatory rulings can cost companies a fortune in lost revenues and extra costs.

Encouragingly though, GSK has a great track record when it comes to getting its products out there. It’s why the company is one of the world’s top 10 biggest pharmaceuticals suppliers by sales.

In fact, the FTSE business is enjoying impressive momentum right now. In late July, it hiked its revenues and adjusted operating profit guidance for the full year. It now expects these to increase a healthy 8-10% and 11-13% respectively.

This is thanks in large part to strong sales in fast-growing segments like HIV. GSK is focused on developing treatments and vaccines in the fields of HIV, infectious diseases, respiratory/immunology and oncology.

It’s a strategy that could deliver outstanding long-term profits growth. And GSK is boosting investment in its drugs pipeline to give it the best chance for success too. R&D spending rose 9% at actual exchange rates to $5.5bn in 2022.

I think the company could deliver solid shareholder returns in the years to come. I’ll be looking to buy it when I next have spare cash to invest.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Royston Wild has no position in any of the shares mentioned. The Motley Fool UK has recommended GSK. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

The FTSE 100’s newest member looks like a no-brainer to me!

This Fool explains why she sees the newest member of the FTSE 100 as a great opportunity after its recent…

Read more »

Investing Articles

Empty Stocks and Shares ISA? Here’s how I’d start earning a second income from scratch

Like the thought of earning extra cash tax free? Our writer explains what he'd do to begin earning passive income…

Read more »

Happy young female stock-picker in a cafe
Investing Articles

No savings at 25? I’d start by investing £3k in these 3 red-hot FTSE 100 shares

Harvey Jones thinks these three FTSE 100 stocks would be a great way to kickstart a portfolio of UK shares.…

Read more »

Young Black woman using a debit card at an ATM to withdraw money
Investing Articles

Up 35% from this year’s low! Here’s where I think Lloyds shares are headed in H2 of 2024

My Lloyds shares are already doing well this year but that’s not guaranteed to continue. What factors could turn the…

Read more »

Investing Articles

Approaching £5, is there still growth ahead for the Rolls-Royce share price?

The Rolls-Royce share price has been flying in the last year. But is there more growth ahead or should investors…

Read more »

Happy young plus size woman sitting at kitchen table and watching tv series on tablet computer
Investing Articles

Could Raspberry Pi be a growth share to buy and hold?

Our writer explains why he thinks a newly-listed UK growth share could have a bright future -- and considers whether…

Read more »

A pastel colored growing graph with rising rocket.
Market Movers

The FTSE 100 jumps after the Bank of England meeting. Here’s what’s next

Jon Smith runs over the takeaways from the Bank of England meeting today and flags up which FTSE 100 stocks…

Read more »

Middle-aged white male courier delivering boxes to young black lady
Investing Articles

How I’d start investing in great value UK shares with £10,000 today

Harvey Jones can see a heap of UK shares he'd like to add to an ISA today. Many combine low…

Read more »